The prevalence of CKD and multi-coronary vessel disease was significantly higher among patients with serum A-FABP levels over the median value than among patients with serum A-FABP levels less than the median value (57% vs. 27%, p < 0.01 and 64% vs. 48%, p = 0.02, respectively). This evidence concerns the gene FABP4 and chronic kidney disease.